Back to LA LINDEN ADVISORS LP

CYCYTOKINETICS INC

Showing 5 of 9 quarters

Position history for LALINDEN ADVISORS LP's holdings in CYTOKINETICS INC

No. Linden Advisors exited its CYTOKINETICS position in Q3 2025. Its Q2 2025 13F listed 175,652,000 shares worth $186.7M. Linden Advisors already held CYTOKINETICS in its Q3 2023 13F, the earliest on record, and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$218.8M

Total Shares Change

-168.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q2
Increased
175.7M
+1.1%
$186.7M1.1%—
48
2025-Q1
Increased
173.7M
+1.5%
$198.9M1.3%—
49
2024-Q4
Increased
171.2M
+1.4%
$204.8M1.7%—
49
2024-Q3
Increased
168.7M
+20.5%
$218.8M1.8%—
58

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used